血脂康胶囊治疗青年高脂血症135例疗效观察  

Efficacy of Xuezhikang Capsule for hyperlipemia in young adult patients

作　　者：李辉[1] 李晓华[1] 李国立[2] 

机构地区：[1]南京军区南京总医院门诊部,江苏南京210002 [2]南京军区南京总医院解放军普通外科研究所,江苏南京210002

出　　处：《医学研究生学报》2009年第10期1042-1044,共3页Journal of Medical Postgraduates

基　　金：国家"十一五"科技支撑计划资助项目(批准号:2006BAI02A06)

摘　　要：目的：为了进一步研究血脂康降脂之外的作用,观察血脂康对青年高脂血症患者血清超敏C反应蛋白（Hs-CRP）的影响。方法：135例青年高脂血症患者（年龄18-39岁）口服血脂康胶囊,每次0.6 g,3次/d,连续服药8周。检测患者血清Hs-CRP和血脂水平。结果：青年高脂血症患者血清Hs-CRP水平明显高于正常值,治疗后血清Hs-CRP水平明显低于治疗前（P〈0.05）。结论：青年高脂血症患者血清Hs-CRP水平明显高于正常,血脂康胶囊除降脂作用之外,还能显著降低血清Hs-CRP水平。Objective： The purpose of this study was to further investigate other effects of Xuezhikang Capsule than blood lipid decreasing,particularly its effect on the high sensitivity C reactive protein（Hs-CRP） in young adult patients with hyperlipemia.Methods： We treated 135 hyperlipemia patients aged 18-39 years with Xuezhikang Capsule at 0.6g tid for 8 successive weeks,followed by detection of the levels of serum Hs-CRP and blood lipid.Results： After Xuezhikang treatment,the level of serum Hs-CRP was significantly decreased in the young adult patients with hyperlipemia（P〈0.05）.Conclusion： Young adult patients with hyperlipemia have an obviously higher level of serum Hs-CRP than normal,and Xuezhikang Capsule can significantly reduce the serum Hs-CRP level in addition to its effect of decreasing the level of blood lipid in these patients.

关 键 词：高脂血症 超敏C反应蛋白 血脂康胶囊 

分 类 号：R589.2[医药卫生—内分泌]